These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 24459397)
1. Use of rodents as models of human diseases. Vandamme TF J Pharm Bioallied Sci; 2014 Jan; 6(1):2-9. PubMed ID: 24459397 [TBL] [Abstract][Full Text] [Related]
3. Genetically engineered models have advantages over xenografts for preclinical studies. Becher OJ; Holland EC Cancer Res; 2006 Apr; 66(7):3355-8, discussion 3358-9. PubMed ID: 16585152 [TBL] [Abstract][Full Text] [Related]
4. The Biology of Malignant Mesothelioma and the Relevance of Preclinical Models. Blanquart C; Jaurand MC; Jean D Front Oncol; 2020; 10():388. PubMed ID: 32269966 [TBL] [Abstract][Full Text] [Related]
5. Human tumor xenografts and mouse models of human tumors: re-discovering the models. Teicher BA Expert Opin Drug Discov; 2009 Dec; 4(12):1295-305. PubMed ID: 23480467 [TBL] [Abstract][Full Text] [Related]
6. Early detection and prevention of pancreatic cancer: use of genetically engineered mouse models and advanced imaging technologies. Mohammed A; Janakiram NB; Lightfoot S; Gali H; Vibhudutta A; Rao CV Curr Med Chem; 2012; 19(22):3701-13. PubMed ID: 22680929 [TBL] [Abstract][Full Text] [Related]
7. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. EFSA GMO Panel Working Group on Animal Feeding Trials Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408 [TBL] [Abstract][Full Text] [Related]
8. Modeling cancer using genetically engineered mice. Stiedl P; Grabner B; Zboray K; Bogner E; Casanova E Methods Mol Biol; 2015; 1267():3-18. PubMed ID: 25636462 [TBL] [Abstract][Full Text] [Related]
9. Current State of Animal (Mouse) Modeling in Melanoma Research. Kuzu OF; Nguyen FD; Noory MA; Sharma A Cancer Growth Metastasis; 2015; 8(Suppl 1):81-94. PubMed ID: 26483610 [TBL] [Abstract][Full Text] [Related]
10. Animal modeling of cancer pathology and studying tumor response to therapy. Langdon SP Curr Drug Targets; 2012 Nov; 13(12):1535-47. PubMed ID: 22974396 [TBL] [Abstract][Full Text] [Related]
11. Preclinical models of meningioma: Cell culture and animal systems. Choudhury A; Raleigh DR Handb Clin Neurol; 2020; 169():131-136. PubMed ID: 32553284 [TBL] [Abstract][Full Text] [Related]
12. Genetically engineered mouse models of brain cancer and the promise of preclinical testing. Huse JT; Holland EC Brain Pathol; 2009 Jan; 19(1):132-43. PubMed ID: 19076778 [TBL] [Abstract][Full Text] [Related]
13. Comparing genetically engineered mouse mammary cancer models with human breast cancer by expression profiling. Shoushtari AN; Michalowska AM; Green JE Breast Dis; 2007; 28():39-51. PubMed ID: 18057542 [TBL] [Abstract][Full Text] [Related]
14. Priceless GEMMs: genetically engineered mouse models for colorectal cancer drug development. Roper J; Hung KE Trends Pharmacol Sci; 2012 Aug; 33(8):449-55. PubMed ID: 22739258 [TBL] [Abstract][Full Text] [Related]